News 3 June 2026 - 4 June 2026

Etihad Orders 10 Boeing Jets, Raising Talk of Hard-to-Get 787 Slots

Stock Market Today: Live Updates 12.07.2026

LIVEMarkets rolling coverageStarted: July 12, 2026, 4:00 AM EDTUpdated: July 13, 2026, 3:54 AM EDT Ocado Shares Drop Over 90% Since 2021, 2026 Slide Fuels Investor Fears July 13, 2026, 3:54 AM EDT. Ocado Group Plc has seen its shares tank more than 90% from July 2021, slumping another 21% in 2026 and rattling investors. The grocery tech firm has struggled with high costs tied to its robotic fulfillment systems, and big partners like Kroger and Sobeys have pulled back, putting more heat on margins. Leadership changes haven’t helped sentiment. Still, latest full-year numbers came in strong, with revenue up
July 12, 2026
Lucyd Stock Gets Wall Street Warning as AI Glasses Shares Near $1

Lucyd Stock Gets Wall Street Warning as AI Glasses Shares Near $1

Lucyd, Inc. shares looked at weaker trading premarket Thursday after Maxim Group downgraded the smart-eyewear firm to Hold from Buy. The broker pointed to a softer gross margin forecast and said Lucyd needs more capital to support expansion. Gross margin is what’s left from sales once product costs are out. The timing here is key. LUCY showed a quote at $0.9600, putting its market cap around $6.05 million and keeping it in the micro-cap bracket—Wall Street shorthand for firms with tiny stock market values. Nasdaq had not opened regular trading yet; normal hours run from 9:30 a.m. to 4 p.m. Eastern, and June 4 is not listed as a market holiday for 2026.
June 4, 2026
Prelude Therapeutics Rises Pre-Market With Focus on Two Cancer Drugs

Prelude Therapeutics Rises Pre-Market With Focus on Two Cancer Drugs

Prelude Therapeutics shares traded higher in premarket action Thursday, after the cancer-drug maker showed up at an investor event in New York on Wednesday. The move brought the stock back into focus for traders. Prelude last traded at $3.66 for a market cap near $302 million. The SPDR S&P Biotech ETF was up 1.6% in its latest trade. The iShares Nasdaq Biotechnology ETF gained 2.0%.
June 4, 2026
bioAffinity Technologies Stock Draws Fresh Attention From Traders

bioAffinity Technologies Stock Draws Fresh Attention From Traders

bioAffinity Technologies Inc. traded at $1.69 in the latest quote, up five cents from its last close. The stock caught a small bump after the diagnostics firm filed a new notice on physician education related to its CyPath Lung cancer test. With a market cap near $7.6 million, any buying or selling tends to swing the share price. Society for Advanced Bronchoscopy is planning a June 16 webinar to talk about CyPath Lung and its use in pulmonary, oncology, and surgical work for early lung cancer detection and management, according to a June 2 filing. Shares and warrants of the company are listed on Nasdaq Capital Market under the symbols BIAF and BIAFW.
June 4, 2026
Sunrise Realty Trust Stock Drops: Why Its 14% Dividend Yield Is Back Under the Microscope

Sunrise Realty Trust Stock Drops: Why Its 14% Dividend Yield Is Back Under the Microscope

Sunrise Realty Trust shares fell 2.9% to $8.49 on Wednesday, leaving the small commercial real estate lender weaker on a day when investors also cut exposure to broader U.S. equities. The Nasdaq-listed stock traded about 62,600 shares and had a stock market value of roughly $113 million. The move matters because there was no fresh company announcement to explain it. Sunrise’s investor-relations page still listed its May 14 first-quarter results as the latest news release, putting the focus back on the loan book, the dividend and thin trading in the shares rather than a new corporate event.
June 4, 2026
Atour Shares Move Higher Ahead of Dividend Date

Atour Shares Move Higher Ahead of Dividend Date

Atour Lifestyle Holdings Ltd shares ticked up 0.83% to $35.27 on Wednesday, outpacing the Nasdaq, as investors looked toward the Chinese hotel company’s dividend eligibility cutoff. The U.S.-listed stock has climbed 7.17% in five sessions but is still down 10.48% for 2026. Atour set Friday, June 5, as the record date for its first 2026 dividend. Investors holding at the close that day get $0.54 per American depositary share, the company said. Payout is expected by around June 22.
June 4, 2026
GCI Liberty Shares Drop as GLIBA’s Liberty Capital Move Feels Squeeze

GCI Liberty Shares Drop as GLIBA’s Liberty Capital Move Feels Squeeze

Liberty Capital Corp shares dropped 3.3% Wednesday. Investors still know it as GCI Liberty Inc. The GLIBA Series A stock finished at $20.50 in after-hours trading in the U.S. Series C shares, GLIBK, matched the drop, last trading at $20.55. Investors are still figuring out how to price the newly named company, now part Alaska network operator and part Liberty-style investment vehicle. The company finished its name change from GCI Liberty to Liberty Capital on May 21 but kept the GLIBA and GLIBK tickers. The Alaska operation will keep using the GCI name. CEO Ron Duncan said the new name points to “expanding investments at the parent level beyond our core Alaska business.”
June 4, 2026
Arxis Shares Slip as $890 Million Deal Puts Pressure on Growth Timing

Arxis Shares Slip as $890 Million Deal Puts Pressure on Growth Timing

Arxis shares dropped Wednesday after the aerospace and defense supplier, which went public recently, announced two deals to expand its electronic-components business. The acquisitions are worth about $890 million. Arxis shares last traded at $41.33, off $1.60, or 3.7%. The stock has moved between $40.865 and $43.175 so far today. At those levels, Arxis’s market cap stood near $16.96 billion, based on market data.
June 4, 2026
NXP Lags Chip Index With Another Test Ahead

NXP Lags Chip Index With Another Test Ahead

NXP Semiconductors N.V. shares fell Wednesday, lagging the rally in chip stocks. Investors looked past the auto and industrial chip supplier, focusing on AI-linked names that climbed faster. The stock closed at $321.88, slipping 0.54%. Shares changed hands between $318.71 and $327.48. The price is still under the $339.95 52-week high from May 27, with traders watching if last month’s rally can stick.
June 4, 2026
Tectonic Therapeutic Stock Climbs as Broader Market Sinks

Tectonic Therapeutic Stock Climbs as Broader Market Sinks

Tectonic Therapeutic shares jumped 3.6% to finish at $28.42 on Nasdaq Wednesday, a big move for the small biotech while the wider U.S. market slipped. MarketScreener data showed the stock was still down 5.2% for the last five sessions but up 36.2% since the start of the year. Biotech was a help. The SPDR S&P Biotech ETF climbed $2.08 to $129.83 and the iShares Nasdaq Biotechnology ETF added $3.25 to $167.50. Tectonic ended ahead of both main biotech benchmarks for the session.
June 4, 2026
GigCapital9 Stock Hangs Close to $10 While Market Slides — The Trade’s Big Unknown

GigCapital9 Stock Hangs Close to $10 While Market Slides — The Trade’s Big Unknown

GigCapital9 Corp. added a penny to close at $9.93 in late U.S. trade Wednesday, holding close to the $9.92-to-$9.93 band with just 1,212 shares trading. The stock barely budged but didn’t slip out of its typical cash-shell pattern. Nasdaq’s regular session was closed at the dateline. The exchange says its usual trading runs from 9:30 a.m. to 4:00 p.m. Eastern. June 3 is not shown as a 2026 market holiday on its schedule.
June 4, 2026
Cenntro Stock Slips as a Tiny Nasdaq EV Name Faces a Fresh Funding Test

Cenntro Stock Slips as a Tiny Nasdaq EV Name Faces a Fresh Funding Test

Cenntro Inc. shares ended lower on Wednesday, closing at $4.37, down 8 cents, or 1.8%, as the electric commercial-vehicle maker remained a thinly traded microcap after a spring reset of its share structure. The move matters because Cenntro is trading only weeks after a 1-for-60 reverse stock split, which cuts the share count and mechanically raises the quoted price per share, and after a planned private placement, a share sale to selected investors rather than the wider public market. For a small company, those events can shape the trade as much as daily business news.
June 4, 2026
Cytek Biosciences Shares Fall After Borealis News and Sales Exit

Cytek Biosciences Shares Fall After Borealis News and Sales Exit

Cytek Biosciences was trading lower Wednesday. Shares last changed hands at $4.05, off 16 cents, down roughly 3.8%. Market cap stood at about $521 million. Around 706,600 shares moved. Investors got more company news to process. Cytek Biosciences plans to unveil a 7-laser cell-analysis system at CYTO 2026, and a new filing said Philippe Busque, senior VP for global sales and services, is set to exit on June 5 for another job. The company said Busque’s exit isn’t tied to any dispute over operations, policies, or practices.
June 4, 2026
NIP Group Shares Spike as Bitcoin Mining Deal Gets Equity Update

NIP Group Shares Spike as Bitcoin Mining Deal Gets Equity Update

NIP Group Inc. ADSs climbed late Wednesday after the company said it completed another step in its bitcoin mining expansion. This latest deal relies more on issuing stock than using debt-like instruments. The U.S.-traded shares were last at $0.4178, up 5.3%, with about 181,000 shares moving. Capital structure shifts with NIP’s new filing as the company pushes deeper into mining. NIP said a second closing wrapped up May 29, issuing 62.6 million Class A ordinary shares to sellers of mined assets. The January closing issued 167.9 million Class A shares. The last stage is also set to be in shares. Previously, convertible notes—debt that turns into stock—had been on the table.
June 4, 2026
Service Properties Trust Drops After Net-Lease Plan Pitch

Service Properties Trust Drops After Net-Lease Plan Pitch

Service Properties Trust dropped 3.5% to end at $1.66 on Wednesday, below its $1.70 open. Investors reacted to the REIT’s new update on reducing debt, selling hotels and shifting to retail net lease properties. Trading volume was 3.93 million on Nasdaq before the close. The timing is key. SVC took the stage at Nareit’s REITweek in New York to argue it’s more of a net lease REIT than just a hotel landlord. Net lease REITs hold properties with tenants who pay under long-term leases and pick up the bills for taxes, insurance and upkeep. President and CEO Chris Bilotto and CFO Brian Donley had a 9:30 a.m. Eastern slot.
June 3, 2026
Arq Drops 4.6% Ahead of Next Major GAC Test

Arq Drops 4.6% Ahead of Next Major GAC Test

Arq, Inc. shares dropped 4.6% to $2.60 late Wednesday in U.S. trading. Around 240,000 shares traded. That’s a steeper decline than the iShares Russell 2000 ETF, which fell 1.4%. $2.60 marked the session low for Arq. Arq shares slipped as the market stayed soft, but investors’ concerns are clear: they want more details on Arq’s granular activated carbon, or GAC, business. GAC is used in filtration to strip out contaminants. Arq said it’s still working on the process design, figuring out capital needs, and looking at timing. The company is aiming to have a new plan in place for the third quarter of 2026.
June 3, 2026
BRP Stock Holds Up as TSX Drops, But Tariffs Remain an Issue

BRP Stock Holds Up as TSX Drops, But Tariffs Remain an Issue

BRP Inc. shares gained Wednesday, outpacing a drop in the wider Canadian market. Investors kept picking up the Ski-Doo, Sea-Doo and Can-Am maker after the company updated its guidance and announced new products, which helped drive the stock higher. Toronto shares finished at C$85.68, picking up C$0.95, or 1.12%, at the 4 p.m. EDT close. The stock started the day at C$84.12, reached as high as C$86.43, and saw 291,680 shares change hands—below its typical 327,460 average volume.
June 3, 2026
GP-Act III Stock Barely Budges as $97.8 Million SPAC Clock Starts Ticking

GP-Act III Stock Barely Budges as $97.8 Million SPAC Clock Starts Ticking

GP-Act III Acquisition Corp. shares ended nearly flat on Wednesday, last quoted at $10.83, down a penny, on just 199 shares traded after the regular Nasdaq session. The market value was about $389.6 million. The quiet tape matters because GP-Act III is a SPAC, or special purpose acquisition company — a listed shell that raises cash to buy a private company and take it public. It has no operating business or revenue, so the stock trades less on earnings momentum and more on cash, deadline risk and deal prospects.
June 3, 2026
Spero Stock Falls With Two Weeks Left Until FDA Decision

Spero Stock Falls With Two Weeks Left Until FDA Decision

Spero Therapeutics shares slipped late Wednesday, missing gains seen in the wider biotech sector. Traders watched for a June 18 U.S. decision on tebipenem HBr, Spero’s antibiotic that’s partnered with GSK. The stock changed hands at $2.80, off 1.1%, giving the company a market cap around $151 million. The SPDR S&P Biotech ETF was ahead 1.5%. Spero shares traded with a clear catalyst ahead. The biotech said the Food and Drug Administration gave a June 18 PDUFA date for tebipenem HBr’s new drug application. That's the target for an FDA decision on whether to approve the drug.
June 3, 2026
Treasure Global Stock Jumps After Company Says Revenue May More Than Double

Treasure Global Stock Jumps After Company Says Revenue May More Than Double

Treasure Global Inc. shares rose on Wednesday after the Malaysia-focused technology company said fiscal 2026 revenue was expected to increase by more than 100%, giving investors a fresh growth marker for one of Nasdaq’s smaller and more volatile listings. The stock was last quoted at $4.45, up 3.7%, after trading between $3.76 and $5.40. Volume reached about 426,000 shares, and the company’s market value stood near $7.5 million, putting it firmly in microcap territory, a term used for very small listed companies that can move sharply on limited trading.
June 3, 2026
Socket Mobile Dips Below $1 Mark Again as Nasdaq Deadline Nears

Socket Mobile Dips Below $1 Mark Again as Nasdaq Deadline Nears

Socket Mobile traded under $1 again Wednesday. The data-capture tech company is still facing a Nasdaq listing issue tied to the price. Last trade was $0.9039, a gain of around 0.4%. Intraday range was $0.90 to $0.98. Volume came in at 229,471 shares, putting the company’s market cap near $7.4 million. Nasdaq notified Socket Mobile on May 19 that its shares closed under $1 for 30 business days in a row. Stocks on the exchange have to keep a bid price of at least $1 to hold on to their listing. Socket needs to get the price back above $1 for at least 10 business days in a row by Nov. 16, 2026, or it risks starting the delisting process.
June 3, 2026
1 118 119 120 121 122 492